Variant report
Variant | nsv972038 |
---|---|
Chromosome Location | chr11:64911552-64913423 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr11:64913265-64913465 | K562 | blood: | n/a | n/a |
2 | CTCF | chr11:64913316-64913394 | K562 | blood: | n/a | n/a |
3 | RAD21 | chr11:64913244-64913549 | HepG2 | liver: | n/a | n/a |
4 | STAT3 | chr11:64912605-64912805 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:64912189..64921319-chr11:64935429..64940801,16 | K562 | blood: | |
2 | chr11:64901191..64904408-chr11:64910543..64914377,7 | MCF-7 | breast: | |
3 | chr11:64902231..64906341-chr11:64907764..64913217,6 | K562 | blood: | |
4 | chr11:64912371..64919818-chr11:64945990..64951836,8 | MCF-7 | breast: | |
5 | chr11:64912434..64914841-chr11:64936262..64938354,2 | K562 | blood: | |
6 | chr11:64892136..64894424-chr11:64912450..64914597,2 | MCF-7 | breast: | |
7 | chr11:64899081..64900910-chr11:64909477..64911964,2 | K562 | blood: | |
8 | chr11:64889640..64891142-chr11:64910547..64912692,2 | K562 | blood: | |
9 | chr11:64901686..64904380-chr11:64908615..64913217,6 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SYVN1-2 | chr11:64913162-64913443 | NONHSAT022092 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU2-23P | TF binding region |
ENSG00000204710 | chromatin interactions |
ENSG00000014216 | chromatin interactions |
ENSG00000162298 | chromatin interactions |
ENSG00000149806 | chromatin interactions |
ENSG00000149792 | chromatin interactions |
ENSG00000254614 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531991812 | chr11:64911554-64911555 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs551662436 | chr11:64911602-64911603 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs72932859 | chr11:64911621-64911622 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs533669313 | chr11:64911631-64911632 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs183897402 | chr11:64911731-64911732 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs543258077 | chr11:64911740-64911741 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs566929579 | chr11:64911746-64911747 | Weak transcription Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs535833052 | chr11:64911820-64911821 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs376030728 | chr11:64911834-64911835 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs369166156 | chr11:64911860-64911861 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs575908606 | chr11:64911861-64911862 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs397962067 | chr11:64911878-64911879 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs75813020 | chr11:64911879-64911880 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs145146457 | chr11:64911908-64911909 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs115162511 | chr11:64911990-64911991 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs558487753 | chr11:64912068-64912069 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs1196049 | chr11:64912123-64912124 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs538724891 | chr11:64912149-64912150 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs535838580 | chr11:64912152-64912153 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs139504620 | chr11:64912153-64912154 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs573558533 | chr11:64912159-64912160 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs114320546 | chr11:64912194-64912195 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs560594059 | chr11:64912197-64912198 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs529348397 | chr11:64912247-64912248 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs543041877 | chr11:64912249-64912250 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs187833896 | chr11:64912289-64912290 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs532029714 | chr11:64912334-64912335 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs552020340 | chr11:64912382-64912383 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
29 | rs565337373 | chr11:64912392-64912393 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
30 | rs192661537 | chr11:64912400-64912401 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
31 | rs542925009 | chr11:64912401-64912402 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
32 | rs149705304 | chr11:64912406-64912407 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
33 | rs117186055 | chr11:64912449-64912450 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
34 | rs56166241 | chr11:64912476-64912477 | Weak transcription Enhancers | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
35 | rs115382721 | chr11:64912610-64912611 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
36 | rs55953837 | chr11:64912806-64912807 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
37 | rs77779771 | chr11:64912880-64912881 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
38 | rs569274511 | chr11:64912986-64912987 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
39 | rs530635102 | chr11:64912989-64912990 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
40 | rs538579006 | chr11:64913016-64913017 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
41 | rs372176848 | chr11:64913050-64913051 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
42 | rs558769816 | chr11:64913074-64913075 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
43 | rs572156574 | chr11:64913129-64913130 | Weak transcription Enhancers | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
44 | rs1149569 | chr11:64913165-64913166 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 5 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs554021607 | chr11:64913180-64913181 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 5 gene(s) | Overlapped CNVs | n/a |
46 | rs574162410 | chr11:64913215-64913216 | Enhancers Weak transcription | Chromatin interactive regionlncRNA | 5 gene(s) | Overlapped CNVs | n/a |
47 | rs55879350 | chr11:64913216-64913217 | Enhancers Weak transcription | Chromatin interactive regionlncRNA | 5 gene(s) | Overlapped CNVs | n/a |
48 | rs543080554 | chr11:64913253-64913254 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 6 gene(s) | Overlapped CNVs | n/a |
49 | rs562888495 | chr11:64913254-64913255 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 6 gene(s) | Overlapped CNVs | n/a |
50 | rs564834221 | chr11:64913262-64913263 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 6 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Chordoma | 21602918 | CNVD |
Melanoma | 18172304 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 16417655 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 17217626 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 21045282 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Prostate cancer | 18779856 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:64903600-64911800 | Weak transcription | Spleen | Spleen |
2 | chr11:64903600-64917400 | Weak transcription | Brain Inferior Temporal Lobe | brain |
3 | chr11:64904200-64913400 | Weak transcription | Primary B cells from cord blood | blood |
4 | chr11:64910200-64912200 | Weak transcription | Liver | Liver |
5 | chr11:64910200-64913000 | Weak transcription | Primary B cells from peripheral blood | blood |
6 | chr11:64910200-64913800 | Weak transcription | HepG2 | liver |
7 | chr11:64911200-64911800 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
8 | chr11:64912200-64915000 | Enhancers | Liver | Liver |
9 | chr11:64913000-64914600 | Enhancers | Primary B cells from peripheral blood | blood |
10 | chr11:64913200-64914600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
11 | chr11:64913200-64914600 | Enhancers | Pancreas | Pancrea |
12 | chr11:64913400-64914400 | Enhancers | Primary B cells from cord blood | blood |